Efficacy and Safety of Mitoxantrone Use in Aggressive Multiple Sclerosis

被引：0
|
作者：
Fabis-Pedrini, Marzena J. [1 ]
Carroll, William M. [1 ,2 ]
Kermode, Allan G. [1 ,2 ,3 ]
机构：
[1] Perron Inst Neurol & Translat Sci, Perth, WA, Australia
[2] Sir Charles Gairdner Hosp, Perth, WA, Australia
[3] Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA, Australia
来源：
NEUROLOGY | 2018年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P3.414
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Safety and tolerability of mitoxantrone use in multiple sclerosis: Phase IV experience with 140 patients on single and combination treatment
    Sadiq, SA
    Sylvester, A
    ANNALS OF NEUROLOGY, 2001, 50 (03) : S56 - S56
  • [42] Improvement in multiple sclerosis-related demyelinating peripheral neuropathy following aggressive mitoxantrone therapy
    Goodman, Brent
    Carter, Jonathan
    Wingerchuk, Dean
    NEUROLOGY, 2008, 70 (11) : A94 - A94
  • [43] Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis
    Tobias, Zrzavy
    Esther, Daniels
    Niklas, Stuka
    Dennis, Weber
    Alexander, Winkelmann
    Helmut, Rauschka
    Michael, Hecker
    Fahmy, Aboulenein-Djamshidian
    Stefanie, Meister
    Fritz, Leutmezer
    Thomas, Berger
    Gabriel, Bsteh
    Klaus, Zettl Uwe
    Paulus, Rommer
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021, 12
  • [44] Continuing evaluation of the safety and tolerability of mitoxantrone in worsening multiple sclerosis: The RENEW study
    Bennett, R
    Al-Sabbagh, A
    NEUROLOGY, 2006, 66 (05) : A29 - A29
  • [45] Ongoing evaluation of the safety and tolerability of mitoxantrone in worsening multiple sclerosis: The RENEW study
    Rivera, Victor
    Al-Sabbagh, Ahmad
    Bennett, Randy
    Coyle, Patricia
    Mikol, Daniel
    Panitch, Hillel
    Fox, Edward
    Rolak, Loren
    Sheremata, William
    Elias, Stanton
    NEUROLOGY, 2007, 68 (12) : A275 - A275
  • [46] Long-term study of mitoxantrone safety profile in progressive multiple sclerosis
    Podlecka-Pietowska, A.
    Zakrzewska-Pniewska, B.
    Kochanowski, J.
    Nojszewska, M.
    Ulinska, B.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S252 - S252
  • [47] Mitoxantrone for worsening multiple sclerosis: Tolerability, toxicity, adherence and efficacy in the clinical setting
    Wundes, Annette
    Kraft, George H.
    Bowen, James D.
    Gooley, Ted A.
    Nash, Richard A.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2010, 112 (10) : 876 - 882
  • [48] Efficacy and Safety of Fingolimod for Multiple Sclerosis in Singapore
    Quek, A. M. L.
    Soon, D.
    Ong, B. K. C.
    Pang, X. J.
    Tye, J. S. N.
    Tan, K.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (03) : 395 - 395
  • [49] Milestones in the Multiple Sclerosis Therapy Safety and efficacy
    Borchers, Anja
    NERVENHEILKUNDE, 2010, 29 (12) : 861 - 861
  • [50] Safety and efficacy of natalizumab in children with multiple sclerosis
    Ghezzi, A.
    Pozzilli, C.
    Grimaldi, L. M. E.
    Morra, V. Brescia
    Bortolon, F.
    Capra, R.
    Filippi, M.
    Moiola, L.
    Rocca, M. A.
    Rottoli, M.
    Sarchielli, P.
    Zaffaroni, M.
    Comi, G.
    NEUROLOGY, 2010, 75 (10) : 912 - 917
12345